To the full analysis
RaySearch Laboratories stock: growth
RAY-B.STRaySearch Laboratories reported $134.79M in revenue for fiscal 2025, up 12.8% on the prior year, up 15.6% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
16.9%
per year from 2006 to 2025, per share 16.9%
Earnings (Annual rate)
10.2%
per year from 2006 to 2025, per share 10.1%
Free cash flow (Annual rate)
19%
per year from 2006 to 2025, per share 19.1%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 15.6% | 13.0% | 16.9% |
| Revenue per share | 15.6% | 13.0% | 16.9% |
| Earnings | no data | 12.5% | 10.2% |
| Earnings per share | no data | 12.5% | 10.1% |
| Free cash flow | 27.6% | 47.1% | 19.0% |
| Free cash flow per share | 27.7% | 47.1% | 19.1% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $6.92M | $3.63M | $1.31M |
| 2007 | $6.49M | $1.98M | $3.58M |
| 2008 | $6.29M | $1.83M | $2.56M |
| 2009 | $8.39M | $3.02M | $4.83M |
| 2010 | $11.8M | $2.9M | $6.05M |
| 2011 | $12.64M | $1.71M | $3.14M |
| 2012 | $18.26M | $1.99M | $3.34M |
| 2013 | $20.5M | −$2.09M | −$2.53M |
| 2014 | $28.6M | $6M | −$759.16K |
| 2015 | $39.87M | $7.04M | $759.16K |
| 2016 | $53.29M | $15.18M | $1.39M |
| 2017 | $58.67M | $11.79M | −$134.76K |
| 2018 | $62.89M | $7.87M | −$4.53M |
| 2019 | $74.36M | $5.05M | $10.84M |
| 2020 | $65.34M | −$910.46K | $10.62M |
| 2021 | $64.34M | −$4.74M | −$1.71M |
| 2022 | $84.59M | $2.38M | $12.56M |
| 2023 | $102.49M | $8.18M | $24.73M |
| 2024 | $119.53M | $20.41M | $26.84M |
| 2025 | $134.79M | $22.84M | $35.99M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = SEK 9.9729)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 4 Nov 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.